Fibroscan

Theoretical Part
Pratical Part
Educational Material
Courses

The FibroScan is a unique, precise, and effective medical device that provides the necessary clinical confidence to aid in the treatment and diagnosis of hepatic patients.
Based on Transient Elastography with Controlled Vibration (VCTE™), the FibroScan offers multiple parameters for a reliable, precise, and reproducible assessment of hepatic tissue stiffness: controlled vibration, controlled energy, and controlled algorithm. In addition to the aforementioned, it is also possible to measure CAP (hepatic steatosis), which, like the measurement of hepatic stiffness, is non-invasive, immediate, and can be performed by an operator not specialized in ultrasonic imaging. The clinical application of FibroScan represents an intelligent solution in the diagnosis and therapeutic definition of hepatic and viral patients, using advanced non-invasive technology.
Services that require: Gastroenterology, Internal Medicine, Infectious Diseases, among others.
MEDICAL AREAS OF INTEREST:


  • Hepatitis B and C;

  • HIV-HCV coinfection;

  • Non-alcoholic fatty liver disease;

  • Alcoholic liver disease;

  • Biliary diseases;

  • Tropical diseases.


ADDITIONAL BENEFITS OF FIBROSCAN:

  • Painless and non-invasive procedure;

  • Immediate presentation of the examination report results;

  • Examinations are reproducible over time;

  • Quick and economically advantageous examination compared to liver biopsy;

  • Reduction in the number of biopsies and, consequently, hospitalizations and number of consultations (for diagnostic evaluation and therapeutic definition);

  • Equipment with probes for children, adults, and obese adults;

  • Possibility of connection to PACS and patient data management;

  • Can be used by an operator without in-depth knowledge of ultrasonic imaging;

  • Easy mobility due to being a portable equipment.


BRIEF EXPLANATION OF THE EXAMINATION:
The measurement is performed in the right lobe of the liver between the ribs. The patient lies supine with the right arm in maximum abduction. The patient should lie on their back in a supine position with the right arm in maximum abduction. The measurement is performed using a probe, which should be located in the right lobe of the liver between the ribs. The probe should always remain perpendicular to the patient's skin throughout the examination. Once the position of the probe, pressure, and perpendicularity have been successfully verified, the operator should then trigger at least 10 successful measurements in the same position. Then, only a few seconds are required for the FibroScan to display the corresponding CAP and elasticity results.
Who can interpret the stiffness results obtained through FibroScan®? The results obtained should be interpreted by an experienced physician taking into account: 1. The patient's complete medical records; 2. The quality of the measurement procedure; 3. Potential factors that influence liver stiffness. How to interpret the stiffness results obtained through FibroScan®? Use of the "Liver Stiffness Interpretation Guide".

Como interpretar os resultados do CAP?


Brochura FibroScan® 430 Mini

FibroScan ® procedure for Users
Find the key recommendations to run a liver examination with FibroScan®


Recommendations for cleaning and disinfecting FibroScan® probes and machine


FibroScan® information for patients

The FibroScan is a unique, precise, and effective medical device that provides the necessary clinical confidence to aid in the treatment and diagnosis of hepatic patients.

Based on Transient Elastography with Controlled Vibration (VCTE™), the FibroScan offers multiple parameters for a reliable, precise, and reproducible assessment of hepatic tissue stiffness: controlled vibration, controlled energy, and controlled algorithm. Additionally, it is possible to measure CAP (hepatic steatosis), which, like the measurement of hepatic stiffness, is non-invasive, immediate, and can be performed by an operator not specialized in ultrasonic imaging. The clinical application of FibroScan represents an intelligent solution in the diagnosis and therapeutic definition of hepatic and viral patients, utilizing advanced non-invasive technology.

Services that require: Gastroenterology, Internal Medicine, Infectious Diseases, among others.

MEDICAL AREAS OF INTEREST:


  • Hepatitis B and C;

  • HIV-HCV coinfection;

  • Non-alcoholic fatty liver disease;

  • Alcoholic liver disease;

  • Biliary diseases;

  • Tropical diseases.


Manual-de-Uso

FibroScan ® procedure for Users
Find the key recommendations to run a liver examination with FibroScan®


Recommendations for cleaning and disinfecting FibroScan® probes and machine


FibroScan® information for patients

Access the webinar recording here:

 



- Webinars temáticos

- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update

- Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

- Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomes

- Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension

- Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non alcoholic fatty liver disease

- Porto-sinusoidal vascular disease: proposal and description of a novel entity

- A relação entre o fígado gordo e a diabetes

Fibroscan for beginner level (certificate)